Abstract
Background: Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been raised as a potential therapy for bilobar metastatic liver disease, although the potential tumor progression (TP) that this technique may induce is still not well established. Methods: The aim of this report was to study tumor hepatic progression induced by the first step of ALPPS in a WAG/Rij rat syngenic model of metastatic colorectal carcinoma by subcapsular inoculation of CC531 cell line. We analyzed the effect of hypoxia and immune response induced by ALPPS on liver metastases. Results: ALLPS seems to induce not only tumor progression, but also metastases independently of the site of inoculation. Immunohistochemical analisys revealed that ALPPS induced expression of hepatic vasculogenic factors and a dramatic increase of intrahepatic macrophages in comparison with non-operated groups. Interestingly, hepatic macrophages strongly expressed COX-2, while tumor-infiltrating macrophages expressed mainly arginase-1. ALPPS also induced a decrease of tumor-infiltrating lymphocytes and increase of intrahepatic T-lymphocytes. Conclusion: ALPPS technique may induce hypoxic environment which enhance hepatic HIF1alpha and VEGF expression. Additionally, the regenerative stimulus seems to be driven by a pro-inflammatory environment, in which M1 intrahepatic macrophages, which expressed COX-2 may develop a key role. These facts may be related with the tumor progression observed in inoculated and operated animals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.